Regentis Biomaterials expanded its clinical trial of GelrinC for the treatment of articular knee cartilage damage to 11 U.S. sites.
Biologics
BoneSupport launched its own U.S. distributor network.
Three Los Angeles-based Cedars-Sinai investigators developed a method to harness stem cells to regrow tissue damaged by major trauma. The Department of Defense and National Institutes of Health awarded the researchers $8 million in grants.
Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.
Vertebral body mesenchymal stem cells derived from whole bone marrow aspirate may provide alternative stem cell sources for spine surgery applications, according to a study in Spine.
Advertisement
LifeNet Health launched the PliaFX Prime allograft surgical solution.
Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).
Reinvent Biologics is a regenerative medicine company.
Platelet-rich plasma injections and stem cell therapies are ushering in a "new dawn" in orthopedics, according to Jason Arora, DO, a board-certified interventional spine and pain management physician at West Orange, N.J.-based Atlantic Spine Center.